Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Linifanib

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Linifanib?

Linifanib is an investigational drug.

There have been 11 clinical trials for Linifanib. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2010.

The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Adenocarcinoma, and Gastrointestinal Neoplasms. The leading clinical trial sponsors are Abbott, Genentech, Inc., and BioGene Pharmaceutical Ltd.

Recent Clinical Trials for Linifanib
Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the EndometriosisBioGene Pharmaceutical Ltd.Phase 1/Phase 2
A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid TumorsAbbottPhase 1
A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors.AbbottPhase 1

See all Linifanib clinical trials

Clinical Trial Summary for Linifanib

Top disease conditions for Linifanib
Top clinical trial sponsors for Linifanib

See all Linifanib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.